Forbes/Thomas Landstreet Update:
For those following this. I had asked about this a day or two ago and now see Thomas tweeting the following explanation for why the Forbes article was taken down:


"Thomas Landstreet
@TomLandstreet
·
46m
(1) Forbes took my post on $CYDY Leronlimab down because they viewed my statements regarding the
@realDonaldTrump
presser misleading.

I greatly appreciate all of the tremendous support I've received over the last few days. I continue to believe deeply in Leronlimab.
Thomas Landstreet
@TomLandstreet
·
40m
(2) I wrote the article because I, like many of you, have been tremendously disappointed by the government's response to Covid-19.

I've done my work on HCQ, Remdesivir $GILD, and Plasma. No treatment on the market even comes close to Leronlimab re efficacy. AND it's safe. $cydy
Thomas Landstreet
@TomLandstreet
·
46m
(3) It's time for our officials to approve Leronlimab for emergency usage - why should a patient die under standard of care when Leronlimab (with a perfect safety profile) could have saved them?

The drug WORKS. "

TWEET LINK